Weight-Loss Drugs Are Driving a Global Protein Price Surge

As blockbuster weight-loss injections such as Mounjaro, Wegovy and Ozempic spread worldwide, an unexpected economic effect is emerging, protein prices are rising fast, and a significant share of the increase is being linked to the millions using these drugs. Dr. Osnat Raziel, a specialist in bariatric surgery and obesity treatment and head of the multidisciplinary obesity center at Assia Medical, Assuta Ramat HaHayal, explains that patients on GLP-1 medicines are being advised to eat more protein to protect muscle mass, strength and physical function while losing weight.

That advice is changing global consumption patterns. Studies show that between 25% and 40% of lost body weight can come from lean mass if diet and exercise are not handled properly, so users are turning to protein powders, fortified drinks, high-protein yogurts, enriched cheeses and dedicated nutrition products. The biggest strain has hit whey protein, with reports that 80% concentrated whey protein has jumped about 90% in a year, and in some products prices are up fivefold since 2023. Producers in Europe and the United States say some supply has already been sold out in advance through 2026, raising fears of a prolonged global shortage.

The shift is also reshaping the food industry. Major companies are redesigning product lines for GLP-1 users, supermarkets are expanding protein shelves, manufacturers are launching items aimed specifically at these patients, and some fast-food chains are reviewing menu changes. In the United States, demand is also rising for peas, lentils and chickpeas used in plant protein production, prompting farmers to move acreage toward protein-rich legumes.

Analysts say a new category of “GLP-1 companion nutrition” has emerged, covering foods, supplements and drinks for weight-loss-drug users. It is expected to grow at double-digit rates and reach billions of dollars. At the same time, a recent British study found that households with GLP-1 users spend hundreds of pounds less a year on food overall, buying less snacks, sweets and processed food, even as protein takes a larger share of the diet. The article says the drugs are not just changing medicine, but the global food chain, and future demand may accelerate new protein technologies and alternative protein sources.